Clinical Trial: An Open-Label, Phase III Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687784) titled 'An Open-Label, Phase III Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia' on June 30.

Brief Summary: The goal of this clinical trial is to see if a new intravenous iron formulation (Ferric Bepectate IV Injection) can treat adult patients with iron deficiency anemia (IDA) by increasing blood hemoglobin (Hb) as an established formulation (Ferric carboxymaltose). It will also learn about the safety of Ferric Bepectate IV Injection. The main questions it aims to answer are:

* Does hemoglobin increase by the same amount 6 weeks after each treatment?

* What me...